VCG — Vietnamese Stock News

Vinaconex (VCG) registers to sell 35.4 million shares of Viwaseen (VIW), reducing stake to 25%, while related An Quy Hung Holding plans to buy 13.34 million shares.

Vinaconex (VCG) to issue 51.7M shares as 8% stock dividend for 2025, raising charter capital to VND 6,982B. New Chairman and CEO appointed.

Vinaconex (VCG) registers to buy 2.2 million GTD shares, boosting total ownership to 48.03% of Giay Thuong Dinh. Transaction runs May 15-June 12.

Vinaconex (VCG) sold just 3.6% of its registered VIW shares due to poor market conditions, reducing stake to 97.5%. It plans further sales to cut ownership to 25%.

Vinaconex (VCG) appoints Nguyen Xuan Dong as Chairman replacing Tran Dinh Tuan. Q1 2026 net profit up 143% YoY to VND 368.5B. Stock up 5 of last 6 sessions.

Vinaconex (VCG) appoints Nguyen Xuan Dong as Chairman replacing Tran Dinh Tuan, who resigned. Dong steps down as CEO, succeeded by Pham Thai Duong.

Vinaconex (VCG) appoints Pham Thai Duong as CEO, sets cautious 2026 plan with profit down 73% and proposes 16% dividend for 2025.

Vinaconex (VCG) replaces CEO Nguyen Xuan Dong with Pham Thai Duong effective April 28. The company targets 2026 net profit of VND 1,037B, down 73% YoY, but maintains 16% dividend.

Vinaconex (VCG) CEO Nguyen Xuan Dong resigns; replaced by Pham Thai Duong. Former chairman arrested for bidding violations. 2026 profit target down 73%.

Vinaconex (VCG) targets 48% ownership in GTD through a 24.03% stake transfer and a VND 2,165B private placement at 10,000 VND/share, funding a mixed-use project.

Vinaconex (VCG) approves acquisition of 18% stake in Aegis Medical from its CEO and family, estimated at 180 billion VND, expanding into healthcare.

Vinaconex (VCG) approved a plan to purchase 2.23 million shares (24.03% stake) in Giay Thuong Dinh (GTD). Analysis of the strategic move and market context.

Vinaconex (VCG) sets 2026 targets: net profit down 73% to VND 1,037B, revenue down 22%, proposes 16% dividend, and adds two new board members.

Vinaconex (VCG) approved a VND 180B deal to buy 18% of Aegis Medical from its CEO's family while setting 2026 revenue at VND 15,423B (-23%) and profit at VND 1,037B (-73%).